Results 81 to 90 of about 358,286 (141)

Magnetic resorcinol-formaldehyde supported Schiff-base/Cu as a robust and recoverable nanocatalyst for the synthesis of tetrahydrobenzo[<i>b</i>]pyrans. [PDF]

Nanoscale Adv
Bazmayon P, Elhamifar D, Kargar S.
europepmc   +1 more source

Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis. [PDF]

RMD Open
Qureshi S, Adas M, Cope PJ, Mahfouz H, Bechman K, Deane KD, El-Gabalawy H, Emery P, Finckh A, Gilbert BTP, Holers VM, Isaacs JD, Kastbom A, Mankia K, Mikuls TR, Pratt AG, Rech J, Russell MD, Schett G, Trouw LA, Turesson C, Beers-Tas MHV, van der Helm-van Mil AHM, van Schaardenburg D, van Steenbergen HW, Toes REM, Cope AP, Galloway J, Norton S.   +28 more
europepmc   +1 more source

Commentary: Health and safety practices and policies concerning human exposure to RF/microwave radiation. [PDF]

Front Public Health
Bailey WH, Foster KR, Chou CK.
europepmc   +1 more source

Association between the sedation type and the risk of major oesophageal injury following increased intraoesophageal temperature during radiofrequency ablation for the treatment of atrial fibrillation. [PDF]

J Thorac Dis
Myrda K, Czarkowski W, Kukfisz A, Popielarz B, Błachut A, Majewski K, Bertagnolli L, Skrzypek M, Gąsior M.   +8 more
europepmc   +1 more source

Scissor-CIBERSORTx Deconvolution Reveals Functional Heterogeneity of CTAL/aTAL Cells and Associated Biomarkers in Renal Fibrosis. [PDF]

Curr Issues Mol Biol
Wang H, Zhang Y, Li J, Fu Y, Wang H.
europepmc   +1 more source

Effectiveness of Radiofrequency Ablation for Chronic Low Back Pain: A Systematic Review of Sham-Controlled Randomized Controlled Trials. [PDF]

J Pain Res
Shokanov T, Anashev T, Baktybergen K, Shaukhin Y.   +3 more
europepmc   +1 more source

Reinforcement Learning-Based Cloud-Aware HAPS Trajectory Optimization in Soft-Switching Hybrid FSO/RF Cooperative Transmission System. [PDF]

Sensors (Basel)
Cui B, Cai S, Wang L, Zhang Z, Wang F.
europepmc   +1 more source

Do high rheumatoid factor levels impact response to certolizumab pegol in patients with inadequately controlled rheumatoid arthritis? A post hoc analysis of the phase IIIb REALISTIC trial. [PDF]

RMD Open
Smolen JS, Mikuls TR, Galloway J, Müller-Ladner U, Curtis JR, Hashimoto M, Takeuchi T, Choy E, Tanaka Y, Cara C, Lauwerys B, Tilt N, Ufuktepe B, Taylor PC.   +13 more
europepmc   +1 more source

Estimating the odds ratio from the output scores of machine learning models: possibilities and limitations. [PDF]

Sci Rep
Nirel R, Bauman N, Morin E, Maimon N, Raz R.   +4 more
europepmc   +1 more source